[Effect of bromocriptine on prolactin secretion after dopaminergic receptor blockade with metoclopramide in patients with prostatic cancer treated with estrogens].
D000368:Aged; D001971:Bromocriptine / Q000627:therapeutic use*; D004054:Diethylstilbestrol / Q000627:therapeutic use*; D004359:Drug Therapy, Combination; D005500:Follow-Up Studies; D006801:Humans; D008297:Male; D008787:Metoclopramide / Q000494:pharmacology; D008875:Middle Aged; D011388:Prolactin / Q000378:metabolism*; D011471:Prostatic Neoplasms / Q000188:drug therapy*; D011954:Receptors, Dopamine / Q000187:drug effects*
D011954:Receptors, Dopamine; D001971:Bromocriptine; D004054:Diethylstilbestrol; D011388:Prolactin; D008787:Metoclopramide
Wpływ bromokryptyny na wydzielanie prolaktyny po zablokowaniu receptorów dopaminergicznych metoklopramidem u chorych z rakiem gruczołu krokowego leczonych estrogenami.